Pluronic F127 Micelles Improve The Stability and Enhance The Anticancer Stem Cell Efficacy of Citral in Breast Cancer

References

• Bray F , FerlayJ, SoerjomataramI, SiegelRL, TorreLA, JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68(6), 394–424 (2018).
   PubMed Web of Science ®Google Scholar
• Saeg F , AnbalaganM. Breast cancer stem cells and the challenges of eradication: a review of novel therapies. Stem Cell Investig.5, 39 (2018).
   PubMedGoogle Scholar
• Gener P , RafaelDF de S, FernándezYet al. Cancer stem cells and personalized cancer nanomedicine. Nanomedicine (Lond.)11(3), 307–320 (2016).
   PubMed Web of Science ®Google Scholar
• Xu X , ChaiS, WangPet al. Aldehyde dehydrogenases and cancer stem cells. Cancer Lett.369(1), 50–57 (2015).
   PubMed Web of Science ®Google Scholar
• Mohammad Sultan KMC . Retinoid signaling in cancer and its promise for therapy. J. Carcinog. Mutagen.S7, 006 (2013).
   Google Scholar
• Vassalli G . Aldehyde dehydrogenases: not just markers, but functional regulators of stem cells. Stem Cells Int.2019, doi: 10.1155/2019/3904645 (2019) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Ginestier C , WicinskiJ, CerveraNet al. Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle8(20), 3297–3302 (2009).
   PubMed Web of Science ®Google Scholar
• Singh S , BrockerC, KoppakaVet al. Aldehyde dehydrogenases in cellular responses to oxidative/electrophilicstress. Free Radic. Biol. Med.56, 89–101 (2013).
   PubMed Web of Science ®Google Scholar
• Parajuli B , FishelML, HurleyTD. Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cells. J. Med. Chem.57(2), 449–461 (2014).
   PubMed Web of Science ®Google Scholar
• Weerawatanakorn M , WuJC, PanMH, HoCT. Reactivity and stability of selected flavor compounds. J. Food Drug Anal.23(2), 176–190 (2015).
   PubMed Web of Science ®Google Scholar
• Naz F , KhanFI, MohammadTet al. Investigation of molecular mechanism of recognition between citral and MARK4: a newer therapeutic approach to attenuate cancer cell progression. Int. J. Biol. Macromol.107(Pt B), 2580–2589 (2018).
   PubMedGoogle Scholar
• Thomas ML , de AntuenoR, CoyleKMet al. Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3. Mol. Oncol.10(9), 1485–1496 (2016).
   PubMed Web of Science ®Google Scholar
• Ailincai D , PorzioW, MarinL. Hydrogels based on imino-chitosan amphiphiles as a matrix for drug delivery systems. Polymers (Basel)12(11), 2687 (2020).
   PubMed Web of Science ®Google Scholar
• Nordin N , YeapSK, RahmanHSet al. In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells. Sci. Rep.9(1), 1614 (2019).
   PubMedGoogle Scholar
• Nordin N , YeapSK, RahmanHSet al. Antitumor and anti-metastatic effects of citral-loaded nanostructured lipid carrier in 4T1-induced breast cancer mouse model. Molecules25(11), 2670 (2020).
   PubMed Web of Science ®Google Scholar
• White B , EvisonA, DombiE, TownleyHE. Improved delivery of the anticancer agent citral using BSA nanoparticles and polymeric wafers. Nanotechnol. Sci. Appl.10, 163–175 (2017).
   PubMed Web of Science ®Google Scholar
• Izham MNM , HussinY, AzizMNMet al. Preparation and characterization of self nano-emulsifying drug delivery system loaded with citraland its antiproliferative effect on colorectal cells in vitro. Nanomaterials9(7), 1028 (2019).
   Web of Science ®Google Scholar
• Palmas L , AroffuM, PetrettoGLet al. Entrapment of Citrus limon var. pompia essential oil or pure citral in liposomes tailored as mouthwash for the treatment of oral cavity diseases. Pharmaceuticals (Basel)13(9), 216 (2020).
   PubMedGoogle Scholar
• Hwang D , RamseyJD, KabanovAV. Polymeric micelles for the delivery of poorly soluble drugs: from nanoformulation to clinical approval. Adv. Drug Deliv. Rev.156, 80–118 (2020).
   PubMed Web of Science ®Google Scholar
• Ma P , GouS, MaYet al. Modulation of drug release by decoration with Pluronic F127 to improve anti-colon cancer activity of electrospun fibrous meshes. Mater. Sci. Eng. C99, 591–598 (2019).
   PubMed Web of Science ®Google Scholar
• Menon JU , KonaS, WadajkarAS, DesaiF, VadlaA, NguyenKT. Effects of surfactants on the properties of PLGA nanoparticles. J. Biomed. Mater. Res. A100A(8), 1998–2005 (2012).
   Web of Science ®Google Scholar
• Batrakova EV , LiS, ElmquistWF, MillerDW, AlakhovVY, KabanovAV. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: selective energy depletion. Br. J. Cancer85(12), 1987–1997 (2001).
   PubMed Web of Science ®Google Scholar
• Ulldemolins A , Seras-FranzosoJ, AndradeFet al. Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics. Cancer Drug Resist.4, 44–68 (2021).
   PubMedGoogle Scholar
• Andrade F , RafaelD, Vilar-HernándezMet al. Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo. J. Control. Release331, 198–212 (2021).
   PubMed Web of Science ®Google Scholar
• Andrade F , FonteP, CostaAet al. Pharmacological and toxicological assessment of innovative self-Assembled polymeric micelles as powders for insulin pulmonary delivery. Nanomedicine (Lond.)11(17), 2305–2317 (2016).
   PubMed Web of Science ®Google Scholar
• Gener P , MonteroS, Xandri-MonjeHet al. Zileuton™ loaded in polymer micelles effectively reduce breast cancer circulating tumor cells and intratumoral cancer stem cells. Nanomedicine24, 102106 (2020).
   PubMed Web of Science ®Google Scholar
• Gener P , GouveiaLP, SabatGRet al. Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells. Nanomedicine11(8), 1883–1892 (2015).
   PubMed Web of Science ®Google Scholar
• Botella P , AbasoloI, FernándezYet al. Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation. J. Control. Release156(2), 246–257 (2011).
   PubMed Web of Science ®Google Scholar
• Rocas P , FernándezY, García-ArandaNet al. Improved pharmacokinetic profile of lipophilic anti-cancer drugs using ανβ3-targeted polyurethane-polyurea nanoparticles. Nanomedicine14(2), 257–267 (2018).
   PubMed Web of Science ®Google Scholar
• Graham CE , BrocklehurstK, PickersgillRW, WarrenMJ. Characterization of retinaldehyde dehydrogenase 3. Biochem. J.394(1), 67–75 (2006).
   PubMedGoogle Scholar
• Eliceiri K , SchneiderCA, RasbandWS, EliceiriKW. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods9(7), 671–675 (2012).
   PubMed Web of Science ®Google Scholar
• Gener P , Seras-FranzosoJ, CallejoPGet al. Dynamism, sensitivity, and consequences of mesenchymal and stem-like phenotype of cancer cells. Stem Cells Int.2018, 4516454 (2018).
   PubMed Web of Science ®Google Scholar
• Sergeant G , VankelecomH, GremeauxL, TopalB. Role of cancer stem cells in pancreatic ductal adenocarcinoma. Nat. Rev. Clin. Oncol.6(10), 580–586 (2009).
   PubMed Web of Science ®Google Scholar
• Espinosa-Cano E , Huerta-MadroñalM, Cámara-SánchezPet al. Hyaluronic acid (HA)-coated naproxen-nanoparticles selectively target breast cancer stem cells through COX-independent pathways. Mater. Sci. Eng. C124, 112024 (2021).
   PubMed Web of Science ®Google Scholar
• Ma F , LiH, LiYet al. Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC). Medicine (Baltimore)96(14), e6561 (2017).
   PubMed Web of Science ®Google Scholar
• Maswal M , DarAA. Inhibition of citral degradation in an acidic aqueous environment by polyoxyethylene alkylether surfactants. Food Chem.138(4), 2356–2364 (2013).
   PubMed Web of Science ®Google Scholar
• Nigjeh SE , YeapSK, NordinN, KamalideghanB, KyH, RosliR. Citral induced apoptosis in MDA-MB-231 spheroid cells. BMC Complement. Altern. Med.18(1), 56 (2018).
   PubMedGoogle Scholar
• Lee JS , KimWG. Potential protective effect of ALDH-1 stromal expression against early recurrence of operable breast cancers. Stem Cell Investig.5, 43 (2018).
   PubMedGoogle Scholar
• Croker AK , Rodriguez-TorresM, XiaYet al. Differential functional roles of ALDH1A1 and ALDH1A3 in mediating metastatic behavior and therapy resistance of human breast cancer cells. Int. J. Mol. Sci.18(10), 2039 (2017).
   PubMed Web of Science ®Google Scholar
• Kim RJ , ParkJR, RohKJet al. High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α. Cancer Lett.333(1), 18–31 (2013).
   PubMed Web of Science ®Google Scholar
• Clark DW , PalleK. Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets. Ann. Transl. Med.4(24), 518 (2016).
   PubMed Web of Science ®Google Scholar
• Uddin MH , KimB, ChoU, AzmiAS, SongYS. Association of ALDH1A1-NEK-2 axis in cisplatin resistance in ovarian cancer cells. Heliyon6(11), e05442 (2020).
   PubMed Web of Science ®Google Scholar
• Ciccone V , TerzuoliE, DonniniS, GiachettiA, MorbidelliL, ZicheM. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells. J. Exp. Clin. Cancer Res.37(1), 311 (2018).
   PubMed Web of Science ®Google Scholar
• Nakahata K , UeharaS, NishikawaSet al. Aldehyde dehydrogenase 1 (ALDH1) is a potential marker for cancer stem cells in embryonal rhabdomyosarcoma. PLoS ONE10(4), e0125454 (2015).
   PubMed Web of Science ®Google Scholar
• Liu P , KumarIS, BrownSet al. Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells. Br. J. Cancer109(7), 1876–1885 (2013).
   PubMed Web of Science ®Google Scholar
• Barbuti AM , ChenZS. Paclitaxel through the ages of anticancer therapy: exploring its role in chemoresistance and radiation therapy. Cancers (Basel)7(4), 2360–2371 (2015).
   PubMed Web of Science ®Google Scholar
• Yokoyama C , SueyoshiY, EmaM, MoriY, TakaishiK, HisatomiH. Induction of oxidative stress by anticancer drugs in the presence and absence of cells. Oncol. Lett.14(5), 6066–6070 (2017).
   PubMed Web of Science ®Google Scholar
• Gener P , RafaelD, Seras-franzosoJet al. Pivotal role of AKT2 during dynamic phenotypic change of breast cancer stem cells. Cancers (Basel)11(8), 1058 (2019).
   PubMed Web of Science ®Google Scholar